Preparation and evaluation of immediate and modified release tablets contained diphenidol hydrochloride

Abstract Motion sickness (MS) is a common phenomenon in life and nearly all individuals will experience MS at least once in their lives. Diphenidol hydrochloride (DPN) is widely used in China for the pharmacotherapy of MS at the dosages of 25 mg every 6–8 h as needed. The conventional DPN tablets ma...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mu-heng Li, Yuan Zeng, Wen Lin, Si-rui Liu, Yu-liang Li, Qiong-zhi Shi, Xiang-yang Xie, Hui Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-08-01
Edice:	Scientific Reports
Témata:	Tablet-in-tablet Rapid drug release Extended drug release Motion sickness Diphenidol hydrochloride
On-line přístup:	https://doi.org/10.1038/s41598-025-17335-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!